Pregled bibliografske jedinice broj: 550907
An open-label randomized phase II trial of oral vitamin D3 supplementation in combination with standard chemotherapy or best supportive care compared with standard chemotherapy and best supportive care in patients with advanced solid tumors.
An open-label randomized phase II trial of oral vitamin D3 supplementation in combination with standard chemotherapy or best supportive care compared with standard chemotherapy and best supportive care in patients with advanced solid tumors. // Journal of Clinical Oncology
Chicago (IL), Sjedinjene Američke Države, 2011. (poster, međunarodna recenzija, sažetak, ostalo)
CROSBI ID: 550907 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
An open-label randomized phase II trial of oral vitamin D3 supplementation in combination with standard chemotherapy or best supportive care compared with standard chemotherapy and best supportive care in patients with advanced solid tumors.
Autori
Trivanovic, Dragan ; Plestina, Stjepko ; Jerin, Lems ; Honovic, Lorena
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo
Izvornik
Journal of Clinical Oncology
/ - , 2011
Skup
ASCO Annual Meeting 2011
Mjesto i datum
Chicago (IL), Sjedinjene Američke Države, 03.06.2011. - 07.06.2011
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
vitamin D; solid tumors
Sažetak
An open-label randomized phase II trial of oral vitamin D3 supplementation in combination with standard chemotherapy or best supportive care compared with standard chemotherapy and best supportive care in patients with advanced solid tumors.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
108-1080058-0047 - Molekularni biljezi u solidnim tumorima - prediktivni i prognostički značaj (Pleština, Stjepko, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
